Sandra P. D’Angelo
Impact in
- Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Polyomavirus and related diseases
- Vascular Tumors and Angiosarcomas
- Pulmonary and Respiratory Medicine top 0.5%
- Sarcoma Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 133
- CAR-T cell therapy research 56
- Cancer Immunotherapy and Biomarkers 36
- Polyomavirus and related diseases 28
- Vascular Tumors and Angiosarcomas 24
-
- Sarcoma Diagnosis and Treatment 59
- Co-authors
- William D. Tap (75 shared papers)Mark A. Dickson (61 shared papers)Gary K. Schwartz (31 shared papers)Cristina R. Antonescu (35 shared papers)Richard D. Carvajal (19 shared papers)Mark G. Kris (14 shared papers)Célèste Lebbé (20 shared papers)Mary Louise Keohan (51 shared papers)
- Journals
- Journal of Clinical Oncology (93 papers)Annals of Oncology (10 papers)Journal for ImmunoTherapy of Cancer (7 papers)Sarcoma (4 papers)Clinical Cancer Research (4 papers)
- Partner nations
- United StatesFranceGermany
In The Last Decade
Sandra P. D’Angelo
184 papers receiving 7.8k citations
Sandra P. D’Angelo's Hit Papers
Peers
Comparison fields: 5 of 113
- Oncology 5.1k
- Pulmonary and Respiratory Medicine 3.0k
- Immunology 1.2k
- Gastroenterology 214
- Pathology and Forensic Medicine 612
Countries citing papers authored by Sandra P. D’Angelo
This map shows the geographic impact of Sandra P. D’Angelo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra P. D’Angelo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra P. D’Angelo more than expected).
Fields of papers citing papers by Sandra P. D’Angelo
This network shows the impact of papers produced by Sandra P. D’Angelo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra P. D’Angelo. The network helps show where Sandra P. D’Angelo may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandra P. D’Angelo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 193 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial Hit paper breakdown → | 2016 | 940 |
| 2 | Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center Hit paper breakdown → | 2015 | 815 |
| 3 | Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials Hit paper breakdown → | 2018 | 509 |
| 4 | Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS -Mutant Cancers Hit paper breakdown → | 2012 | 505 |
| 5 | Phase II Trial of the CDK4 Inhibitor PD0332991 in Patients With Advanced CDK4 -Amplified Well-Differentiated or Dedifferentiated Liposarcoma Hit paper breakdown → | 2013 | 321 |
| 6 | 2018 | 271 | |
| 7 | 2014 | 241 | |
| 8 | 2018 | 238 | |
| 9 | 2016 | 229 | |
| 10 | 2011 | 218 | |
| 11 | 2016 | 216 | |
| 12 | 2016 | 150 | |
| 13 | 2013 | 146 | |
| 14 | 2012 | 142 | |
| 15 | 2020 | 137 | |
| 16 | 2014 | 122 | |
| 17 | 2013 | 117 | |
| 18 | 2005 | 105 | |
| 19 | 2010 | 102 | |
| 20 | 2016 | 100 |
About Sandra P. D’Angelo
Sandra P. D’Angelo is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Molecular Biology and Ecology, having authored 193 papers that have together received 7.9k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (59 papers), CAR-T cell therapy research (56 papers), Immunotherapy and Immune Responses (37 papers), Cancer Immunotherapy and Biomarkers (36 papers), Polyomavirus and related diseases (28 papers), Vascular Tumors and Angiosarcomas (24 papers), Bacteriophages and microbial interactions (16 papers) and Plant Virus Research Studies (15 papers). The work is most often cited by research in Oncology (5.1k citations), Pulmonary and Respiratory Medicine (3.0k citations), Immunology (1.2k citations), Gastroenterology (214 citations) and Pathology and Forensic Medicine (612 citations). Sandra P. D’Angelo has collaborated with scholars based in United States, France and Germany. Frequent co-authors include William D. Tap, Mark A. Dickson, Gary K. Schwartz, Cristina R. Antonescu, Richard D. Carvajal, Mark G. Kris, Célèste Lebbé, Mary Louise Keohan, Mrinal M. Gounder and Patrick Terheyden. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal for ImmunoTherapy of Cancer, Sarcoma and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.